Current Suspected Overdose Deaths in Delaware for 2024: Get Help Now!

Find school water testing results and additional resources

Attention Medicaid Participants: Eligibility Renewals Restarted April 1, 2023

Delaware.gov logo

DHSS Press Release



Rita Landgraf, Secretary
Carl Kanefsky, Communications Director
(302) 255-9047, Pager
Email: carl.kanefsky@delaware.gov

Date: April 18, 2011
DHSS-35-2011





SIXTH ANTI-VIRAL RESISTANT FLU CASE IDENTIFIED


Delaware's Division of Public Health (DPH) laboratory results confirm a sixth Delaware case of antiviral-resistant influenza for the 2010 - 2011 flu season. A 55 year-old woman from Kent County was infected with an influenza strain found to be resistant to oseltamivir, the preferred treatment antiviral medication used to treat confirmed cases of influenza. There is no reason to change treatment approaches at this time. There are four influenza antiviral medications approved for use in the United States: oseltamivir (brand name Tamiflu), zanamivir (brand name Relenza), amantadine (Symmetrel, generic) and rimantadine (Flumadine, generic).

Although it is late in the flu season, as always DPH recommends the following precautions for both the public and clinicians:

Stay informed about the latest developments on the flu by visiting www.flu.delaware.gov

Delaware Health and Social Services is committed to improving the quality of the lives of Delaware's citizens by promoting health and well-being, fostering self-sufficiency, and protecting vulnerable populations.

Delaware Health and Social Services is committed to improving the quality of the lives of Delaware's citizens by promoting health and well-being, fostering self-sufficiency, and protecting vulnerable populations.





+